Chlorhexidine-based decolonization to reduce healthcare-associated infections and multidrug-resistant organisms (MDROs): who, what, where, when, and why?

Published:September 05, 2019DOI:


      Body surface decolonization with chlorhexidine bathing and nasal mupirocin has become a simple solution for prevention of healthcare-associated infections. The clinical trial evidence for this practice will be reviewed to understand who benefits from this practice, for what reasons, and at what times. The method of bathing and nasal decolonization will also be discussed as proper application is needed for maximal effectiveness. Finally, the conflict between current effectiveness and future potential for fueling resistance is considered.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Manor J.
        • Blum N.
        • Lurie Y.
        “No good deed goes unpunished”: Ignaz Semmelweis and the story of puerperal fever.
        Infect Control Hosp Epidemiol. 2016; 37: 881-887
        • Berríos-Torres S.I.
        • Umscheid C.A.
        • Bratzler D.W.
        • Leas B.
        • Stone E.C.
        • Kelz R.R.
        • et al.
        Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.
        JAMA Surg. 2017; 152: 784-791
        • Global Guidelines for the Prevention of Surgical Site Infection World Health Organization
        WHO guidelines approved by the guidelines review committee.
        • Allegranzi B.
        • Sax H.
        • Pittet D.
        Hand hygiene and healthcare system change within multi-modal promotion: a narrative review.
        J Hosp Infect. 2013; 83: S3-S10
        • Platt R.
        • Polk B.F.
        • Murdock B.
        • Rosner B.
        Reduction of mortality associated with nosocomial urinary tract infection.
        Lancet. 1983; 1: 893-897
        • Davies G.E.
        • Francis J.
        • Martin A.R.
        • Rose F.L.
        • Swain G.
        1:6-di-4′-chlorophenyldiguanidohexane (“hibitane”). laboratory investigation of a new antibacterial agent of high potency.
        Br J Pharmacol Chemother. 1954; 9: 192-196
        • Lowbury E.J.
        The Practitioner. 1957; 179: 489-493
        • Lilly H.A.
        • Lowbury E.J.
        Disinfection of the skin: an assessment of some new preparations.
        Br Med J. 1971; 3: 674-676
        • Lowbury E.J.
        • Lilly H.A.
        Use of 4 per cent chlorhexidine detergent solution (Hibiscrub) and other methods of skin disinfection.
        Br Med J. 1973; 1: 510-515
        • Ayliffe G.A.
        • Bridges K.
        • Lilly H.A.
        • Lowbury E.J.
        • Varney J.
        • Wilkins M.D.
        Comparison of two methods for assessing the removal of total organisms and pathogens from the skin.
        J Hyg (Lond). 1975; 75: 259-274
        • Lowbury E.J.
        • Ayliffe G.A.
        Proceedings: Alcoholic solutions and other agents for disinfection of the surgeon's hands.
        J Clin Pathol. 1975; 28: 753-754
        • Lilly H.A.
        • Lowbury E.J.
        Transient skin flora: their removal by cleansing or disinfection in relation to their mode of deposition.
        J Clin Pathol. 1978; 31: 919-922
        • Lilly H.A.
        • Lowbury E.J.
        • Wilkins M.D.
        Limits to progressive reduction of resident skin bacteria by disinfection.
        J Clin Pathol. 1979; 32: 382-385
        • Lilly H.A.
        • Lowbury E.J.
        • Wilkins M.D.
        Detergents compared with each other and with antiseptics as skin ‘degerming’ agents.
        J Hyg (Lond). 1979; 82: 89-93
        • Ayliffe G.A.
        • Noy M.F.
        • Babb J.R.
        • Davies J.G.
        • Jackson J.
        A comparison of pre-operative bathing with chlorhexidine-detergent and non-medicated soap in the prevention of wound infection.
        J Hosp Infect. 1983; 4: 237-244
        • Davies J.
        • Babb J.R.
        • Ayliffe G.A.
        The effect on the skin flora of bathing with antiseptic solutions.
        J Antimicrob Chemother. 1977; 3: 473-481
        • Gjermo P.
        Chlorhexidine in dental practice.
        J Clin Periodontol. 1974; 1: 143-152
        • Maki D.G.
        • Ringer M.
        • Alvarado C.J.
        Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
        Lancet. 1991; 338: 339-343
        • Mimoz O.
        • Pieroni L.
        • Lawrence C.
        • Edouard A.
        • Costa Y.
        • Samii K.
        • et al.
        Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
        Crit Care Med. 1996; 24: 1818-1823
        • Mimoz O.
        • Villeminey S.
        • Ragot S.
        • Dahyot-Fizelier C.
        • Laksiri L.
        • Petitpas F.
        • et al.
        Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
        Arch Intern Med. 2007; 167: 2066-2072
        • Mimoz O.
        • Lucet J.C.
        • Kerforne T.
        • Pascal J.
        • Souweine B.
        • Goudet V.
        • et al.
        • CLEAN trial investigators
        Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
        Lancet. 2015; 386: 2069-2077
        • Darouiche R.O.
        • Wall Jr., M.J.
        • Itani K.M.
        • Otterson M.F.
        • Webb A.L.
        • Carrick M.M.
        • et al.
        Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis.
        N Engl J Med. 2010; 362: 18-26
        • Mangram A.J.
        • Horan T.C.
        • Pearson M.L.
        • Silver L.C.
        • Jarvis W.R.
        Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
        Infect Control Hosp Epidemiol. 1999; 20: 250-278
        • Vernon M.O.
        • Hayden M.K.
        • Trick W.E.
        • Hayes R.A.
        • Blom D.W.
        • Weinstein R.A.
        Chicago Antimicrobial Resistance Project (CARP). Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci.
        Arch Intern Med. 2006; 166: 306-312
        • Bleasdale S.C.
        • Trick W.E.
        • Gonzalez I.M.
        • Lyles R.D.
        • Hayden M.K.
        • Weinstein R.A.
        Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients.
        Arch Intern Med. 2007; 167: 2073-2079
        • Popovich K.J.
        • Hota B.
        • Hayes R.
        • Weinstein R.A.
        • Hayden M.K.
        Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit.
        Infect Control Hosp Epidemiol. 2009; 30: 959-963
        • Popovich K.J.
        • Lyles R.
        • Hayes R.
        • Hota B.
        • Trick W.
        • Weinstein R.A.
        • et al.
        Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate.
        Infect Control Hosp Epidemiol. 2012; 33: 889-896
        • Mody L.
        • Washer L.L.
        • Kaye K.S.
        • Gibson K.
        • Saint S.
        • Reyes K.
        • et al.
        Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?.
        Clin Infect Dis. 2019 Apr 13; ([Epub ahead of print])
        • Huang S.S.
        • Rifas-Shiman S.L.
        • Warren D.K.
        • Fraser V.J.
        • Climo M.W.
        • Wong E.S.
        • et al.
        Centers for Disease Control and Prevention Epicenters Program. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.
        J Infect Dis. 2007; 195: 330-338
        • Huang S.S.
        • Rifas-Shiman S.L.
        • Pottinger J.M.
        • Herwaldt L.A.
        • Zembower T.R.
        • Noskin G.A.
        • et al.
        • Centers for Disease Control and Prevention Epicenters Program
        Improving the assessment of vancomycin-resistant enterococci by routine screening.
        J Infect Dis. 2007; 195 ([Epub 2006 Dec 27]): 339-346
        • Boldt A.C.
        • Schwab F.
        • Rohde A.M.
        • Kola A.
        • Bui M.T.
        • Märtin N.
        • et al.
        Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital.
        PLoS One. 2018; 13e0201548
        • Hamprecht A.
        • Rohde A.M.
        • Behnke M.
        • Feihl S.
        • Gastmeier P.
        • Gebhardt F.
        • et al.
        • DZIF-ATHOS Study Group
        Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
        J Antimicrob Chemother. 2016; 71: 2957-2963
        • Latour K.
        • Huang T.D.
        • Jans B.
        • Berhin C.
        • Bogaerts P.
        • Noel A.
        • et al.
        Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.
        PLoS One. 2019; 14e0214327
        • Manzur A.
        • De Gopegui E.R.
        • Dominguez M.
        • Mariscal D.
        • Gavalda L.
        • Perez J.L.
        • et al.
        • Spanish Network for Research in Infectious Diseases
        Clinical significance of methicillin-resistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain.
        Epidemiol Infect. 2012; 140: 400-406
        • Hogardt M.
        • Proba P.
        • Mischler D.
        • Cuny C.
        • Kempf V.A.
        • Heudorf U.
        Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.
        Euro Surveill. 2015; 20 (pii: 21171)
        • Horner C.
        • Parnell P.
        • Hall D.
        • Kearns A.
        • Heritage J.
        • Wilcox M.
        Meticillin-resistant Staphylococcus aureus in elderly residents of care homes: colonization rates and molecular epidemiology.
        J Hosp Infect. 2013; 83: 212-218
        • Chen H.
        • Au K.M.
        • Hsu K.E.
        • Lai C.K.
        • Myint J.
        • Mak Y.F.
        • et al.
        Multidrug-resistant organism carriage among residents from residential care homes for the elderly in Hong Kong: a prevalence survey with stratified cluster sampling.
        Hong Kong Med J. 2018; 24: 350-360
        • McKinnell J.A.
        • Singh R.D.
        • Miller L.G.
        • Kleinman K.
        • Gussin G.
        • He J.
        • et al.
        CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program. The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California.
        Clin Infect Dis. 2019 Feb 11; ([Epub ahead of print])
        • Mody L.
        • Foxman B.
        • Bradley S.
        • McNamara S.
        • Lansing B.
        • Gibson K.
        • et al.
        Longitudinal assessment of multidrug-resistant organisms in newly admitted nursing facility patients: implications for an evolving population.
        Clin Infect Dis. 2018; 67: 837-844
        • McKinnell J.A.
        • Miller L.G.
        • Singh R.
        • Kleinman K.
        • Peterson E.M.
        • Evans K.D.
        • et al.
        Prevalence of and factors associated with Multidrug Resistant Organism (MDRO) colonization in 3 nursing homes.
        Infect Control Hosp Epidemiol. 2016; 37: 1485-1488
        • Trick W.E.
        • Weinstein R.A.
        • DeMarais P.L.
        • Kuehnert M.J.
        • Tomaska W.
        • Nathan C.
        • et al.
        Colonization of skilled-care facility residents with antimicrobial-resistant pathogens.
        J Am Geriatr Soc. 2001; 49: 270-276
        • March A.
        • Aschbacher R.
        • Dhanji H.
        • Livermore D.M.
        • Böttcher A.
        • Sleghel F.
        • et al.
        Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria.
        Clin Microbiol Infect. 2010; 16: 934-944
        • Rhee Y.
        • Palmer L.J.
        • Okamoto K.
        • Gemunden S.
        • Hammouda K.
        • Kemble S.K.
        • et al.
        • Centers for Disease Control And Prevention Epicenter Program
        Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery.
        Infect Control Hosp Epidemiol. 2018; 39: 405-411
        • Lin M.Y.
        • Lolans K.
        • Blom D.W.
        • Lyles R.D.
        • Weiner S.
        • Poluru K.B.
        • et al.
        • Centers for Disease Control and Prevention Epicenter Program
        The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients.
        Infect Control Hosp Epidemiol. 2014; 35: 440-442
        • Edmiston Jr., C.E.
        • Lee C.J.
        • Krepel C.J.
        • Spencer M.
        • Leaper D.
        • Brown K.R.
        • et al.
        Evidence for a standardized preadmission showering regimen to achieve maximal antiseptic skin surface concentrations of chlorhexidine gluconate, 4%, in surgical patients.
        JAMA Surg. 2015; 150: 1027-1033
        • Liu C.
        • Bayer A.
        • Cosgrove S.E.
        • Daum R.S.
        • Fridkin S.K.
        • Gorwitz R.J.
        • et al.
        • Infectious Diseases Society of America
        Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
        Clin Infect Dis. 2011; 52: e18-e55
        • Bode L.G.
        • Kluytmans J.A.
        • Wertheim H.F.
        • Bogaers D.
        • Vandenbroucke-Grauls C.M.
        • Roosendaal R.
        • et al.
        Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.
        N Engl J Med. 2010; 362: 9-17
        • Harbarth S.
        • Fankhauser C.
        • Schrenzel J.
        • Christenson J.
        • Gervaz P.
        • Bandiera-Clerc C.
        • et al.
        Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.
        JAMA. 2008; 299: 1149-1157
        • Climo M.W.
        • Yokoe D.S.
        • Warren D.K.
        • Perl T.M.
        • Bolon M.
        • Herwaldt L.A.
        • et al.
        Effect of daily chlorhexidine bathing on hospital-acquired infection.
        N Engl J Med. 2013; 368: 533-542
        • Huang S.S.
        • Septimus E.
        • Kleinman K.
        • Moody J.
        • Hickok J.
        • Avery T.R.
        • et al.
        • CDC Prevention Epicenters Program
        AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection.
        N Engl J Med. 2013; 368: 2255-2265
        • Milstone A.M.
        • Elward A.
        • Song X.
        • Zerr D.M.
        • Orscheln R.
        • Speck K.
        • et al.
        Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial.
        Lancet. 2013; 381: 1099-1106
      1. Mupirocin-Iodophor ICU Decolonization Swap Out Trial. [last accessed September 8, 2019].

        • Huang S.S.
        • Septimus E.
        • Kleinman K.
        • Moody J.
        • Hickok J.
        • Heim L.
        • et al.
        • ABATE Infection trial team
        Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
        Lancet. 2019; 393: 1205-1215
        • Huang S.S.
        • Singh R.
        • McKinnell J.A.
        • Park S.
        • Gombosev A.
        • Eells S.J.
        • et al.
        • Project CLEAR Trial
        Decolonization to Reduce Post-discharge Infection Risk among MRSA Carriers.
        N Engl J Med. 2019; 380: 638-650
        • Bellini C.
        • Petignat C.
        • Masserey E.
        • Büla C.
        • Burnand B.
        • Rousson V.
        • et al.
        Universal screening and decolonization for control of MRSA in nursing homes: a cluster randomized controlled study.
        Infect Control Hosp Epidemiol. 2015; 36: 401-408
      2. Protect Trial: Protecting nursing homes from Infections and Hospitalization. [last accessed September 8, 2019].

      3. Miller LG, McKinnell JA, Singh R, Gussin G, Kleinman K, Saavedra R, et al. Universal Decolonization in Nursing Homes: Effect of Chlorhexidine and Nasal Povidone-Iodine on Prevalence of MultiDrug-Resistant Organisms (MDROs) in the PROTECT Trial. Abstract 680256. IDWeek (Joint Meeting of IDSA, SHEA, HIVMA, and PIDS), October 2–6, 2019 (Washington DC).

        • Edgeworth J.D.
        Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care.
        J Antimicrob Chemother. 2011; 66: ii41-ii47
        • Weiner L.M.
        • Webb A.K.
        • Walters M.S.
        • Dudeck M.A.
        • Kallen A.J.
        Policies for Controlling Multidrug-Resistant Organisms in US Healthcare Facilities Reporting to the National Healthcare Safety Network, 2014.
        Infect Control Hosp Epidemiol. 2016; 37: 1105-1108
      4. Shuman EK, Harpe JM, Calfee DP. Survey of Hospital Practices Regarding Use of Chlorhexidine Gluconate Bathing for Prevention of Healthcare-Associated Infections. IDWeek Abstract; [last accessed September 8, 2019].

        • Septimus E.
        • Hickok J.
        • Moody J.
        • Kleinman K.
        • Avery T.R.
        • Huang S.S.
        • et al.
        Closing the Translation Gap: toolkit based implementation of universal decolonization in adult intensive care units reduces central line associated bloodstream infections in 95 community hospitals.
        Clin Infect Dis. 2016 May; 63 (PMID: 27143669): 172-177
      5. McKinnell JA, Singh RD, Miller LG, Gussin G, Kleinman K, Saavedra R, et al. CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program. The SHIELD Orange County Project: A Decolonization Strategy in 35 Hospitals and Nursing Homes Reduces Multi-Drug Resistant Organism (MDRO) Prevalence in a Southern California Region. IDWeek (Joint Meeting of IDSA, SHEA, HIVMA, and PIDS), October 2-6, 2019 (Washington DC).

      6. SHIELD: Eliminating Multidrug-Resistant Organisms. University of California Irvine Health. Hospital, Nursing Home, and Long-Term Acute Care Hospital Toolkits for Decolonization. and [last accessed September 8, 2019].

      7. Miller LG, McKinnell JA, Singh R, Kleinman K, Gombosev A, Dutciuc T, et al. Reduction of MDRO Colonization in Nursing Home Residents with Routine Use of Chlorhexidine Bathing and Nasal Iodophor (Project PROTECT). IDWeek (5th Annual Joint Meeting of IDSA, SHEA, HIVMA, and PIDS), October 26–30, 2016 (New Orleans, LA).

      8. Heim L, Dutciuc T, Singh R, Estevez M, Tjoa T, Chang J, et al. Double Swab 5% vs Single Swab 10% Iodophor for Reducing MRSA with Routine Chlorhexidine Bathing (Abstract 8775). Society for Healthcare Epidemiology of America (SHEA) Annual Spring Meeting, March 29-31, 2017, (St. Louis, MO).

        • Raulji C.M.
        • Clay K.
        • Velasco C.
        • Yu L.C.
        Daily bathing with chlorhexidine and its effects on nosocomial infection rates in pediatric oncology patients.
        Pediatr Hematol Oncol. 2015; 32: 315-321
        • Hayden M.K.
        • Lin M.Y.
        • Lolans K.
        • Weiner S.
        • Blom D.
        • Moore N.M.
        • et al.
        • Centers for Disease Control and Prevention Epicenters Program
        Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals.
        Clin Infect Dis. 2015; 60: 1153-1161
        • Swan J.T.
        • Ashton C.M.
        • Bui L.N.
        • Pham V.P.
        • Shirkey B.A.
        • Blackshear J.E.
        • et al.
        Effect of chlorhexidine bathing every other day on prevention of hospital-acquired infections in the surgical icu: a single-center, randomized controlled trial.
        Crit Care Med. 2016; 44: 1822-1832
        • Ammerlaan H.S.
        • Kluytmans J.A.
        • Berkhout H.
        • Buiting A.
        • de Brauwer E.I.
        • van den Broek P.J.
        • et al.
        • MRSA Eradication Study Group
        Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.
        J Antimicrob Chemother. 2011 Oct; 66: 2409-2417
        • Popovich K.J.
        • Hota B.
        • Hayes R.
        • Weinstein R.A.
        • Hayden M.K.
        Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit.
        Intensive Care Med. 2010; 36: 854-858
        • Supple L.
        • Kumaraswami M.
        • Kundrapu S.
        • Sunkesula V.
        • Cadnum J.L.
        • Nerandzic M.M.
        • et al.
        Chlorhexidine only works if applied correctly: use of a simple colorimetric assay to provide monitoring and feedback on effectiveness of chlorhexidine application.
        Infect Control Hosp Epidemiol. 2015; 36: 1095-1097
      9. Universal ICU Decolonization: an enhanced protocol. Agency for Healthcare Research and Quality. [last accessed September 8, 2019].

      10. Active Bathing to Eliminate (ABATE) Infection. NIH Collaboratory Living Textbook. [last accessed September 8, 2019].

        • Huang S.S.
        • Septimus E.
        • Hayden M.K.
        • Kleinman K.
        • Sturtevant J.
        • Avery T.R.
        • et al.
        Impact of body surface decolonization on bacteriuria and candiduria in a cluster-randomized trial of intensive care units.
        Lancet Infect Dis. 2016; 16: 70-79
      11. Staff Skills Assessment: CHG Cloth Observation Checklist. SHIELD: Eliminating Multidrug-Resistant Organisms. University of California Irvine Health. Hospital Toolkit for decolonization. [last accessed September 8, 2019].

        • Batra R.
        • Cooper B.S.
        • Whiteley C.
        • Patel A.K.
        • Wyncoll D.
        • Edgeworth J.D.
        Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit.
        Clin Infect Dis. 2010; 50: 210-217
        • Chávez-Moreno S.
        • Camacho-Ortiz A.
        Chlorhexidine bathing every other day still does the trick, but it may come at a cost.
        Ann Transl Med. 2016; 4: 555
        • Hayden M.K.
        • Lolans K.
        • Haffenreffer K.
        • Avery T.R.
        • Kleinman K.
        • Li H.
        • et al.
        Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial.
        J Clin Microbio. 2016; 54: 2735-2742